MiniMed Fit Payload Wear Study
Minimed Fit Payload Wear Study
1 other identifier
observational
175
1 country
4
Brief Summary
The purpose of this study is to assess success/failure of the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period to support development of the future commercialized patch pump.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Feb 2026
Shorter than P25 for all trials
4 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 6, 2026
CompletedFirst Posted
Study publicly available on registry
February 13, 2026
CompletedStudy Start
First participant enrolled
February 19, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 1, 2026
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2026
CompletedMarch 12, 2026
February 1, 2026
2 months
February 6, 2026
March 11, 2026
Conditions
Outcome Measures
Primary Outcomes (1)
The MiniMed Fit Payload success rate at the end of Day 5.
The number of MiniMed Fit Payload that meet the success criteria divided by the total number of MiniMed Fit Payload devices applied at the end of Day 5.
5 Days
Secondary Outcomes (1)
The MiniMed Fit Payload success rate at the end of Day 7.
7 Days
Study Arms (1)
MiniMed Fit Payload adhesive components
Adult participants with insulin-requiring diabetes using the MiniMed Fit Payload adhesive components in different wear locations over a 7-day period.
Interventions
The MiniMed Fit Payload device used in this study will be made of polycarbonate materials, will not contain any electronic or mechanical components, and is intended to mimic the shape and weight of a future product. Each device will consist of the payload assembly and an adhesive patch, which will be adhered to the payload on one side and the subject's skin on the other.
Eligibility Criteria
Investigational Centers, example, primary care clinic, academic institution, etc.
You may qualify if:
- Subjects with insulin- requiring diabetes
- Subjects 18 years of age or older
- Subjects able and willing to sign informed consent
You may not qualify if:
- Subjects who report known skin sensitivity or allergy to pressure-sensitive adhesives, e.g, medical device adhesives, band-aids, other acrylic-containing adhesives
- Subjects with any skin condition in the area where device placement (e.g., irritation, rash, infection) could occur, per subject report.
- Subjects who are pregnant (per self-report) at initial screening. If a subject becomes pregnant during the study, the site will follow procedures for study withdrawal.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (4)
ProSciento
Chula Vista, California, 91911-1350, United States
Headlands Research California LLC
Escondido, California, 92025-6428, United States
NYC Research Inc
Long Island City, New York, 11106-2329, United States
Rainer Clinical Research Center
Renton, Washington, 98057-5211, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 6, 2026
First Posted
February 13, 2026
Study Start
February 19, 2026
Primary Completion
May 1, 2026
Study Completion
May 1, 2026
Last Updated
March 12, 2026
Record last verified: 2026-02
Data Sharing
- IPD Sharing
- Will not share